FDA and Duke Collaborate to Modernize Clinical Trials

[yoast-breadcrumb]

Under an agreement between the U.S. Food and Drug Administration and Duke University Medical Center, Duke will host a Public-Private Partnership that will include broad representation from government, industry, patient advocacy groups, professional societies, and academia.

PDF icon Download Press Release (58.61 KB)

New CTTI Recommendations Provide Path for More Efficient Clinical Trials Using Clinical Registries

[yoast-breadcrumb]

CTTI Project: Registry Trials

Newly released recommendations from the Clinical Trials Transformation Initiative (CTTI) have the potential to streamline clinical trials by using registry information. Registries are data collection tools typically used to better understand long-term trends in a specific population, such as patients with a particular disease or patients exposed to a certain treatment.

PDF icon Download Press Release (194.86 KB)